FDA DEVICE FACTS
ETEST Delafloxacin (DFX) (0.002-32 µg/mL)
Biomerieux S.A.
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
ETEST® is a manual, quantitative technique for determination of antimicrobial susceptibility of non-fastidious Gram -negative and Gram -positive aerobic bacteria and fastidious bacteria. The system comprises a predefined antibioti c gradient which is used to determine the Minimum Inhibitory Concentration (MIC, in μg/mL) of different antimicrobial agents against microorganisms tested on agar media after overnight incubation. Delafloxacin has been shown to be active against the aerobic microorganisms listed below according to the FDA label for this antimicrobial agent. ETEST® DFX can be used to determine the MIC of D elafloxacin against the following microorganisms: Active both in vitro and in clinical infections: Gram-positive bacteria:
• Staphylococcus aureus (including methicillin-resistant and methicillin-susceptible strains)
• Staphylococcus haemolyticus
• Staphylococcus lugdunensis
• Enterococcus faecalis Gram-negative bacteria:
• Pseudomonas aeruginosa
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。